FDA-approved GLP-1 pill offers cheaper, needle-free option for weight loss
KENT COUNTY, Mich. — A new oral version of the weight loss drug Wegovy has been approved by…
Influencer Taking Mounjaro Explains First-Hand Effects Of Weight-Loss Drug
Weight loss medications can be a tempting solution for those looking to shed extra kilos quickly. More often…
Experts’ advice on how to maintain weight loss after stopping Mounjaro and Ozempic jabs
Weight-loss drugs such as Mounjaro have been praised for triggering dramatic weight loss for about 1.6 million people…
California is ending coverage for weight loss drugs, despite TrumpRx
SACRAMENTO — Many low-income Californians prescribed wildly popular weight-loss drugs will lose their coverage for the medications in the new…
Doctors warn major changes coming for weight loss drugs in Mass.
Patients and doctors are bracing as some major insurers get ready to roll out changes to coverage for…
2 No-Brainer Healthcare Stocks to Buy Now
Pfizer’s acquisition of obesity drugmaker Metsera positions the pharmaceutical giant to compete in a market expected to reach…
Mounjaro mounts to top spot in Indian drug market; Oct sales touch ₹100 cr, ETPharma
New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…
GLP-1 goliath updates demand for top weight loss drug
Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy,…
Is Eli Lilly a Millionaire Maker?
Eli Lilly’s GLP-1 drug portfolio should power the business for at least the next decade. But the market…
Ozempic at Costco? Discount Giant Expands Into $100 Billion Weight-Loss Drug Market
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Costco…
Warning after ‘King Kong’ of weight-loss jabs found being sold illegally on social media
Fake versions of highly sought-after weight-loss jabs are being sold illegally on social media, an investigation has found.…
Ozempic coming soon to India: What is it? Benefits, side effects and controversies
India’s drug controller, the Central Drugs Standard Control Organisation (CDSCO), approved Ozempic (semaglutide) on 26 September for use…